Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 82.83 Million CNY | 31.67% |
| 2022 | 105.48 Million CNY | 4.17% |
| 2021 | 101.26 Million CNY | 972.67% |
| 2020 | 9.44 Million CNY | -95.21% |
| 2019 | 197.02 Million CNY | 52.73% |
| 2018 | 129 Million CNY | -6.99% |
| 2017 | 138.7 Million CNY | -28.71% |
| 2016 | 194.56 Million CNY | -23.54% |
| 2015 | 254.46 Million CNY | 20.17% |
| 2014 | 211.76 Million CNY | 69.32% |
| 2013 | 125.06 Million CNY | 636.63% |
| 2012 | 16.97 Million CNY | -19.49% |
| 2011 | 21.08 Million CNY | 165.67% |
| 2010 | 7.93 Million CNY | 128.1% |
| 2009 | -28.24 Million CNY | -1060.09% |
| 2008 | 2.94 Million CNY | -30.9% |
| 2007 | 4.25 Million CNY | 125.71% |
| 2006 | 1.88 Million CNY | -79.58% |
| 2005 | 9.23 Million CNY | -26.62% |
| 2004 | 12.58 Million CNY | 142.65% |
| 2003 | -29.51 Million CNY | 68.92% |
| 2002 | -94.98 Million CNY | -122.03% |
| 2001 | -42.77 Million CNY | -543.16% |
| 2000 | 9.65 Million CNY | 166.2% |
| 1999 | -14.58 Million CNY | -176.81% |
| 1998 | 18.98 Million CNY | 93.14% |
| 1997 | 9.82 Million CNY | -36.01% |
| 1996 | 15.36 Million CNY | -30.33% |
| 1995 | 22.04 Million CNY | -44.87% |
| 1994 | 39.99 Million CNY | -12.93% |
| 1993 | 45.93 Million CNY | 73.31% |
| 1992 | 26.5 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 16.15 Million CNY | -50.51% |
| 2024 Q3 | 26.7 Million CNY | 63.52% |
| 2024 Q1 | 32.64 Million CNY | 877.51% |
| 2023 Q3 | 30.77 Million CNY | 50.41% |
| 2023 Q1 | 32.74 Million CNY | 443.43% |
| 2023 Q2 | 20.45 Million CNY | -37.53% |
| 2023 FY | 138.88 Million CNY | 31.67% |
| 2023 Q4 | -4.19 Million CNY | -113.65% |
| 2022 Q4 | -9.53 Million CNY | -123.19% |
| 2022 Q2 | 17.29 Million CNY | -43.78% |
| 2022 Q3 | 41.11 Million CNY | 137.73% |
| 2022 FY | 105.48 Million CNY | 4.17% |
| 2022 Q1 | 30.76 Million CNY | 37.31% |
| 2021 Q2 | 33.71 Million CNY | 6.66% |
| 2021 Q1 | 31.61 Million CNY | 114.73% |
| 2021 FY | 101.26 Million CNY | 972.67% |
| 2021 Q3 | 13.53 Million CNY | -59.87% |
| 2021 Q4 | 22.4 Million CNY | 65.58% |
| 2020 Q1 | 17.31 Million CNY | 68.04% |
| 2020 Q2 | 31.15 Million CNY | 79.99% |
| 2020 Q3 | -171.97 Million CNY | -651.97% |
| 2020 Q4 | -214.59 Million CNY | -24.78% |
| 2020 FY | 9.44 Million CNY | -95.21% |
| 2019 FY | 197.02 Million CNY | 52.73% |
| 2019 Q4 | 10.3 Million CNY | -64.42% |
| 2019 Q3 | 28.94 Million CNY | -30.73% |
| 2019 Q2 | 41.79 Million CNY | 52.99% |
| 2019 Q1 | 27.31 Million CNY | -51.23% |
| 2018 Q3 | 5.93 Million CNY | -83.56% |
| 2018 Q4 | 56 Million CNY | 843.92% |
| 2018 FY | 129 Million CNY | -6.99% |
| 2018 Q1 | 30.97 Million CNY | -34.67% |
| 2018 Q2 | 36.08 Million CNY | 16.47% |
| 2017 Q2 | 29.43 Million CNY | 9.96% |
| 2017 Q3 | 35.07 Million CNY | 19.17% |
| 2017 Q4 | 47.41 Million CNY | 35.17% |
| 2017 FY | 138.7 Million CNY | -28.71% |
| 2017 Q1 | 26.76 Million CNY | -65.78% |
| 2016 Q3 | 36.12 Million CNY | -7.46% |
| 2016 Q2 | 39.03 Million CNY | -5.2% |
| 2016 FY | 194.56 Million CNY | -23.54% |
| 2016 Q4 | 78.22 Million CNY | 116.55% |
| 2016 Q1 | 41.17 Million CNY | -51.27% |
| 2015 Q2 | 54.21 Million CNY | -0.48% |
| 2015 Q1 | 54.48 Million CNY | 1.61% |
| 2015 FY | 254.46 Million CNY | 20.17% |
| 2015 Q4 | 84.5 Million CNY | 37.93% |
| 2015 Q3 | 61.26 Million CNY | 13.0% |
| 2014 Q4 | 53.61 Million CNY | -0.04% |
| 2014 FY | 211.76 Million CNY | 69.32% |
| 2014 Q2 | 67.45 Million CNY | 82.01% |
| 2014 Q1 | 37.05 Million CNY | -44.37% |
| 2014 Q3 | 53.63 Million CNY | -20.48% |
| 2013 Q3 | 21.61 Million CNY | -30.59% |
| 2013 FY | 125.06 Million CNY | 636.63% |
| 2013 Q4 | 66.62 Million CNY | 208.26% |
| 2013 Q1 | 5.69 Million CNY | -2.6% |
| 2013 Q2 | 31.13 Million CNY | 446.6% |
| 2012 Q2 | 10.35 Million CNY | 141.35% |
| 2012 Q3 | -3.5 Million CNY | -133.9% |
| 2012 Q4 | 5.84 Million CNY | 266.66% |
| 2012 FY | 16.97 Million CNY | -19.49% |
| 2012 Q1 | 4.28 Million CNY | 4.01% |
| 2011 FY | 21.08 Million CNY | 165.67% |
| 2011 Q4 | 4.12 Million CNY | 658.89% |
| 2011 Q3 | 543.3 Thousand CNY | -93.65% |
| 2011 Q2 | 8.55 Million CNY | 8.71% |
| 2011 Q1 | 7.86 Million CNY | 174.0% |
| 2010 Q3 | 3.6 Million CNY | -65.85% |
| 2010 Q1 | 4.39 Million CNY | 111.14% |
| 2010 Q2 | 10.56 Million CNY | 140.67% |
| 2010 FY | 7.93 Million CNY | 128.1% |
| 2010 Q4 | -10.63 Million CNY | -394.58% |
| 2009 Q2 | 7.45 Million CNY | 3662.51% |
| 2009 FY | -28.24 Million CNY | -1060.09% |
| 2009 Q4 | -39.42 Million CNY | -1100.8% |
| 2009 Q3 | 3.93 Million CNY | -47.13% |
| 2009 Q1 | -209.16 Thousand CNY | 97.8% |
| 2008 Q3 | 6.81 Million CNY | 41.89% |
| 2008 FY | 2.94 Million CNY | -30.9% |
| 2008 Q1 | 808.1 Thousand CNY | -48.89% |
| 2008 Q2 | 4.8 Million CNY | 494.66% |
| 2008 Q4 | -9.49 Million CNY | -239.19% |
| 2007 Q1 | 681.01 Thousand CNY | 121.86% |
| 2007 Q4 | 1.58 Million CNY | 278.83% |
| 2007 Q3 | -884.13 Thousand CNY | -130.71% |
| 2007 Q2 | 2.87 Million CNY | 322.79% |
| 2007 FY | 4.25 Million CNY | 125.71% |
| 2006 Q2 | 4.87 Million CNY | 664.92% |
| 2006 Q3 | -510.2 Thousand CNY | -110.47% |
| 2006 Q4 | -3.11 Million CNY | -510.71% |
| 2006 FY | 1.88 Million CNY | -79.58% |
| 2006 Q1 | 637.31 Thousand CNY | 130.72% |
| 2005 Q4 | -2.07 Million CNY | -167.68% |
| 2005 Q1 | 2.62 Million CNY | 1678.0% |
| 2005 Q2 | 5.62 Million CNY | 114.45% |
| 2005 Q3 | 3.06 Million CNY | -45.49% |
| 2005 FY | 9.23 Million CNY | -26.62% |
| 2004 FY | 12.58 Million CNY | 142.65% |
| 2004 Q1 | -8.58 Million CNY | 17.34% |
| 2004 Q2 | 14 Million CNY | 263.05% |
| 2004 Q3 | 7.02 Million CNY | -49.83% |
| 2004 Q4 | 147.51 Thousand CNY | -97.9% |
| 2003 Q2 | -4.34 Million CNY | 24.06% |
| 2003 Q4 | -10.39 Million CNY | -14.62% |
| 2003 Q1 | -5.71 Million CNY | 91.64% |
| 2003 Q3 | -9.06 Million CNY | -108.76% |
| 2003 FY | -29.51 Million CNY | 68.92% |
| 2002 Q3 | -9.36 Million CNY | -6.4% |
| 2002 FY | -94.98 Million CNY | -122.03% |
| 2002 Q1 | -8.43 Million CNY | 0.0% |
| 2002 Q2 | -8.8 Million CNY | -4.31% |
| 2002 Q4 | -68.37 Million CNY | -630.2% |
| 2001 FY | -42.77 Million CNY | -543.16% |
| 2000 FY | 9.65 Million CNY | 166.2% |
| 1999 FY | -14.58 Million CNY | -176.81% |
| 1998 FY | 18.98 Million CNY | 93.14% |
| 1997 FY | 9.82 Million CNY | -36.01% |
| 1996 FY | 15.36 Million CNY | -30.33% |
| 1995 FY | 22.04 Million CNY | -44.87% |
| 1994 FY | 39.99 Million CNY | -12.93% |
| 1993 FY | 45.93 Million CNY | 73.31% |
| 1992 FY | 26.5 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.9 Billion CNY | 98.313% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.39 Billion CNY | 97.559% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 788.26 Million CNY | 89.491% |
| Aurora Optoelectronics Co.,Ltd. | -505.31 Million CNY | 116.394% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -37.56 Million CNY | 320.496% |
| NanJing Pharmaceutical Company Limited | 1.49 Billion CNY | 94.448% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 114.81 Million CNY | 27.848% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.36 Billion CNY | 93.932% |